Literature DB >> 12860800

Topical fundus pulsation measurement in patients with active central serous chorioretinopathy.

Michael Tittl1, Elzbieta Polska, Karl Kircher, Andreas Kruger, Noemi Maar, Michael Stur, Leopold Schmetterer.   

Abstract

OBJECTIVE: To determine regional pulsatile choroidal blood flow using laser interferometry in patients with active central serous chorioretinopathy (CSC).
METHOD: The study compared an equally sized age-, sex-, and refractive error-matched control group of healthy volunteers obtained from the Department of Clinical Pharmacology with 18 consecutive patients who had newly diagnosed active, unilateral CSC obtained from the University of Vienna Eye Clinic, Vienna, Austria. MAIN OUTCOME MEASURES: Regional fundus pulsation amplitude as assessed using laser interferometry.
RESULTS: The median age of the patients was 40 years; the male-female ratio was 16:2. Foveal fundus pulsation amplitude was significantly higher in eyes with CSC (mean [SD], 5.5 [1.7] micro m) than in the eyes of the control subjects (4.1 [1.1] micro m; P =.005). In addition, eyes with CSC had a significantly higher variability in fundus pulsation amplitude (mean [SD], 48% [20%]) assessed at different fundus locations around the leak than the controls did (20% [9%]; P<.001).
CONCLUSIONS: To our knowledge, this is the first study that measures topical fundus pulsations in patients who have active, unilateral CSC. These data indicate a generally increased foveal pulsatile choroidal blood flow and an abnormal distribution of fundus pulsation amplitude in the area close to the leak. Whether these findings reinforce the concept that choroidal perfusion abnormalities play a role in the pathogenesis of CSC remains to be established.

Entities:  

Mesh:

Year:  2003        PMID: 12860800     DOI: 10.1001/archopht.121.7.975

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up.

Authors:  A Arsan; H S Kanar; A Sonmez
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

3.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

4.  Acute uveal effusion during phacoemulsification with preoperative central serous chorioretinopathy: a case report.

Authors:  Ruiqi Chang; Yu Du; Zhou Peng; Yi Lu; Xiangjia Zhu
Journal:  BMC Ophthalmol       Date:  2017-08-03       Impact factor: 2.209

Review 5.  The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes.

Authors:  Konstantinos Giannopoulos; Maria Gazouli; Klio Chatzistefanou; Anthi Bakouli; Marilita M Moschos
Journal:  J Genomics       Date:  2021-01-01

Review 6.  Pachychoroid: current concepts on clinical features and pathogenesis.

Authors:  Veronica Castro-Navarro; Francine Behar-Cohen; Woohyok Chang; Antonia M Joussen; Timothy Y Y Lai; Rafael Navarro; Ian Pearce; Yasuo Yanagi; Annabelle A Okada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-15       Impact factor: 3.117

Review 7.  Pachychoroid diseases of the macula.

Authors:  Roberto Gallego-Pinazo; Rosa Dolz-Marco; Francisco Gómez-Ulla; Sarah Mrejen; K Bailey Freund
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

8.  Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy.

Authors:  Yalong Dang; Xinfeng Sun; Yongsheng Xu; Yalin Mu; Manli Zhao; Jing Zhao; Yu Zhu; Chun Zhang
Journal:  Ther Clin Risk Manag       Date:  2014-01-09       Impact factor: 2.423

9.  Retinal and choroidal changes in steroid-associated central serous chorioretinopathy.

Authors:  Vikas Ambiya; Abhilash Goud; Mohammed Abdul Rasheed; Sankeert Gangakhedkar; Kiran Kumar Vupparaboina; Jay Chhablani
Journal:  Int J Retina Vitreous       Date:  2018-04-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.